2004
DOI: 10.1016/j.brainres.2003.12.037
|View full text |Cite
|
Sign up to set email alerts
|

Erythropoietin and the nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
109
0
5

Year Published

2006
2006
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 164 publications
(115 citation statements)
references
References 102 publications
1
109
0
5
Order By: Relevance
“…Accordingly, we observed a reduction of cell survival with prolonged hypoxic exposure and significantly reduced expression of two important target genes, namely Epo and Glut-1, after treatment with roscovitine confirming impairment of the hypoxic signaling cascade. Other in vitro models have also shown that neurons exposed to hypoxia significantly upregulate Glut-1 and Epo (Genc et al, 2004) mRNA and protein levels.…”
Section: Discussionmentioning
confidence: 94%
“…Accordingly, we observed a reduction of cell survival with prolonged hypoxic exposure and significantly reduced expression of two important target genes, namely Epo and Glut-1, after treatment with roscovitine confirming impairment of the hypoxic signaling cascade. Other in vitro models have also shown that neurons exposed to hypoxia significantly upregulate Glut-1 and Epo (Genc et al, 2004) mRNA and protein levels.…”
Section: Discussionmentioning
confidence: 94%
“…This antagonizing effect was associated with perturbation of the oscillatory calcium signal triggered by mGluR5 activation. EPO exerts its biological functions through a cell surface receptor, which has been known to be expressed in the cerebral cortex, midbrain, and hippocampus of the CNS (1,3,26). EPO is expressed both in neurons and astrocytes and recent studies demonstrated that EPO receptor (EPOR) is expressed in cultured astrocytes (27).…”
Section: Epo Inhibits Group I Mglur-induced Increase In Hypotonic Swementioning
confidence: 99%
“…recent years emerged as one of the most efficient neuroprotective agents (1)(2)(3). It is well documented from both experimental and clinical studies that erythropoietin (EPO) attenuates the degree of brain damage after stroke (4)(5)(6).…”
mentioning
confidence: 99%
“…It is predominantly produced in the fetal liver and adult kidney, but can also be expressed by neurons, glial cells and the cerebrovascular endothelium. It was shown that EPO could actin an angiogenic, neuroprotective and neurotrophic manner in addition to its promoting role in haematopoiesis [34] . The efficacy of EPO was evaluated in patients with optic neuritis due to its neuroprotective properties by Sühs and colleagues [35] .…”
Section: Erythropoietinmentioning
confidence: 99%